Trouble With CRISPR? Maybe – But Maybe Not – Seeking Alpha
|
Trouble With CRISPR? Maybe – But Maybe Not
Seeking Alpha Now, here is a paper that is causing a stir. Published in Nature Methods, researchers from Stanford, the University of Iowa, and Columbia are reporting that CRISPR treatment in mice introduces far more mutations than thought. The news sent the stocks … Rodger Novak Sells 616 Shares of Crispr Therapeutics AG (CRSP) Stock Crispr Therapeutics AG (CRSP) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPS Short Interest in Crispr Therapeutics AG (CRSP) Increases By 10.2% |
